W. Ling

Infectious Diseases · 2020

A researcher in the Science corpus: 1 paper; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom W. Ling trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Guangdi Li

Papers from W. Ling's perspective

Ordered by how strongly the researchers W. Ling trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study (The Lancet)
  2. A novel coronavirus outbreak of global health concern (The Lancet)
  3. CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV) (Radiology)
  4. Pathological findings of COVID-19 associated with acute respiratory distress syndrome (The Lancet Respiratory Medicine)
  5. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission (Science China Life Sciences)
  6. Therapeutic options for the 2019 novel coronavirus (2019-nCoV) (Nature reviews. Drug discovery)
  7. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV (Nature Communications)
  8. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses (Science Translational Medicine)
  9. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease (mBio)
  10. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro (Cell Research)

Their papers